MG

Michael Gladstone

Atlas Venture

Greater Boston

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Investments

Pheon Therapeutics

Series A

Total Funding: $190M

Diagonal Therapeutics

Series A

Total Funding: $130M

SAPI

Undisclosed

Total Funding: $10M

Versanis Bio

Series A

Total Funding: $70M

Day One Biopharmaceuticals

Series A

Total Funding: $190M

Third Harmonic Bio

Series A

Total Funding: $50M

Spero Therapeutics

Seed

Total Funding: $120M

Surface Oncology

Series A

Total Funding: $35M

Work Experience

Atlas Venture

2015

  • Partner

    2020

  • Principal

    2015

Atlas Venture

2012 - 2014

  • Associate

    2012 - 2014

L.E.K. Consulting

2009 - 2012

  • Senior Associate Consultant

    2009 - 2012

Eutropics Pharmaceuticals

2009 - 2009

  • MLSC Fellow

    2009 - 2009